Progesterone receptor activation – an alternative to SERMs in breast cancer.

Authors: Desreux J, Kebers F, Noel A, Francart D, Van Cauwenberge H, Heinen V, Thomas JL, Bernard AM, Paris J, Delansorne R, Foidart JM.

Publication Year: 2000

Citation: Eur J Cancer 2000;36 Suppl 4:S90-1.

This review emphasizes progesterone’s role in supporting healthy breast homeostasis and opposing the proliferative effects of estradiol in the breast, unlike synthetic progestins.

http://www.ncbi.nlm.nih.gov/pubmed/11056336